Ustekinumab Improves Health-Related Quality of Life in Korean and Taiwanese Patients With Moderate to Severe Psoriasis: Results from the PEARL Trial
August 2012 | Volume 11 | Issue 8 | Original Article | 943 | Copyright © August 2012
Tsen-Fang Tsai MD,a Michael Song MD,b Yaung-Kaung Shen PhD,b Brad Schenkel MS,c Yong-Beom Choe MD,d Nack-In Kim MD,e Joo-Heung Lee MD,f Ju-Hee Lee MD,g Hae-Jun Song MD,h and Jai-Il Youni on behalf of the PEARL investigators
aDepartment of Dermatology, National Taiwan University Hospital, Taipei, Taiwan bJanssen Research & Development, LLC, Spring House, PA cJanssen Scientific Affairs, LLC, Horsham, PA dKonkuk University School of Medicine, Seoul, South Korea eKyung Hee University Medical Center, Seoul, South Korea fSamsung Medical Center, Sungkyunkwan University, Seoul, South Korea gYonsei University College of Medicine Severence Hospital, Seoul, South Korea hKorea University Guro Hospital, Seoul, South Korea iSeoul National University, Seoul, South Korea
You will have 48 hours to download the full-text PDF
